Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | SHBG | P04278 | 2/20 | 0.33 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22633740 | 0.67 | ALDH1A1 (0.31) | LMNA | |
| SCHEMBL322133 | 0.63 | ALDH1A1 (0.36) | LMNA | |
| SCHEMBL10243182 | 0.60 | — | — | |
| SCHEMBL14919575 | 0.60 | CYP3A4 (0.35) | CYP3A4 | |
| SCHEMBL22054349 | 0.60 | CYP19A1 (0.32) | ESR1ARESR2LMNAGPBAR1 | |
| SCHEMBL4452438 | 0.58 | — | — | |
| SCHEMBL4452444 | 0.58 | — | — | |
| SCHEMBL4452440 | 0.58 | — | — | |
| SCHEMBL4174623 | 0.58 | APOBEC3A (0.30) | — | |
| SCHEMBL19387503 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240358603-A1 | One-Part Dental Adhesive Composition for Fixing Dental Composite Materials | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-10-31 | — | — | US | disclosed |
| US-12070514-B2 | One-part dental adhesive composition for fixing dental composite materials | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-08-27 | — | — | US | disclosed |
| EP-4106710-A1 | ASCORBIC ACID COMPONENT FOR USE IN A METHOD OF TREATING THE SURFACE OF A PREPARED TOOTH | 3M Innovative Properties Company (US) | 2022-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358603-A1 | One-Part Dental Adhesive Composition for Fixing Dental Composite Materials | CDH1, F12, ACTN1 | ESR1 772/4885AR 2263/4885ESR2 3437/4885 |
| US-12070514-B2 | One-part dental adhesive composition for fixing dental composite materials | CDH1, F12, ACTN1 | ESR1 772/4885AR 2263/4885ESR2 3437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.